Genetic deletion or functional disruption of Cx3cr1 has been shown to exacerbate dopaminergic neuronal loss, with corresponding increases in pro-inflammatory cytokine production and ROS activity in multiple PD mouse models (Nash et al., 2015; Castro-Sánchez et al., 2018). This evidence concerns the gene CX3CR1 and Parkinson disease.